Safety and immunogenicity of phoP/phoQ-deleted Salmonella typhi expressing Helicobacter pylori urease in adult volunteers

Vaccine

Volumn 18, Issue 5-6, 1999, Pages 449-459

  Dipetrillo, Melissa D ^a   Tibbetts, Timothy ^b   Kleanthous, Harry ^b   Killeen, Kevin P ^c   Hohmann, Elizabeth L ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b Acambis   (United States)

^c AVANT Immunotherapeutics Inc   (United States)

Author keywords

Bacterial vector; Helicobacter pylori; Human study; Innoculation, oral; Salmonella typhi; Urease

Indexed keywords

IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; TYPHOID VACCINE; UREASE;

ADULT; ARTICLE; CONTROLLED STUDY; DRUG SAFETY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE CONSTRUCT; GENE TRANSFER; HELICOBACTER PYLORI; HUMAN; HUMAN EXPERIMENT; IMMUNOGENICITY; MALE; NORMAL HUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; SALMONELLA TYPHI; SEROCONVERSION; VIRULENCE;

ADULT; ANTIGENS, BACTERIAL; BACTERIAL PROTEINS; BACTERIAL VACCINES; FEMALE; HELICOBACTER PYLORI; HUMANS; IMMUNITY, MUCOSAL; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; MALE; MIDDLE AGED; SALMONELLA TYPHI; UREASE; VACCINES, SYNTHETIC;

EID: 0032873474     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(99)00246-7     Document Type: Article

References (33)

1. Tacket C.O., Kelly S.M., Schodel F., Losonsky G., Nataro J.P., Edelman R., Levine M.M., Curtiss III R. Safety and immunogenicity in humans of an attenuated Salmonella typhi vaccine vector strain expressing plasmid encoded hepatitis B antigens stabilized by the asd-balanced lethal vector system. Infect. Immun. 65:1997;3381-3385.
2. Nardelli-Haefliger D., Kraehenbuhl J.P., Curtiss III R., Schodel F., Potts A., Kelly S., DeGrandi P. Oral and rectal immunization of adult female volunteers with a recombinant attenuated Salmonella typhi vaccine strain. Infect. Immun. 64:1996;5219-5224.
3. Gonzales C., Hone D., Noriega F.R., Tacket C.O., Davies J.R., Losonsky G., Nataro P., Hoffman S., Malik A., Nardin E., Sztein M.B., Heppner D.G., Fouts T.R., Isibasi A., Levine M.M. Salmonella typhi vaccine strain CVD908 expressing the circumsporozoite protein of Plasmodium falciparum: strain construction and safety and immunogenicity in humans. J. Infect. Dis. 169:1994;927-931.
4. Hohmann E.L., Oletta C.A., Killeen K.P., Miller S.I. phoP/phoQ-deleted Salmonella typhi (Ty800) is a safe and immunogenic single dose typhoid fever vaccine in volunteers. J. Infect. Dis. 173:1996;1408-1414.
5. Wick M., Harding C.V., Twesten N.J., Normark S.J., Pfeifer J.D. The phoP locus influences processing and presentation of S. typhimurium antigens by activated macrophages. Mol. Micro. 16:1995;465-470.
6. Lee C.K., Weltzin R. Jr, Thomas W.D., et al. Oral immunization with recombinant Helicobacter pylori urease induces secretory IgA antibodies and protects mice from challenge with Helicobacter felis. J. Infect. Dis. 172:1995;161-172.
7. Corthesy-Theulaz I., Hopkins S., Bachmann D., Saldinger P., Porta N., Haas R., Zheng-Xin Y., Meyer T., Bousourene H., Blum A.L., Kraehenbuhl J.P. Mice are protected from Helicobacter pylori infecton by nasal immunization with attenuated Salmonella typhimurium expressing urease A and B subunits. Infect. Immun. 66:1998;581-586.
8. Gomez-Duarte O.G., Lucas B., Yan Z.X., Panthel K., Haas R., Meyer T.F. Protection of mice against gastric colonization by Helicobacter pylori by single oral dose immunization with attenuated Salmonella typhimurium producing urease subunits A and B. Vaccine. 16:1998;460-471.
9. Nakayama K., Kelly S., Curtiss III R. Construction of an Asd+ expression-cloning vector: stable maintenance and high level expression of cloned genes in a Salmonella vaccine strain. Bio/Tech. 6:1988;693-697.
10. Miller S.I., Kukral A., Mekalanos J.J. A two component regulatory system phoP/phoQ controls Salmonella typhimurium virulence. Proc. Natl. Acad. Sci. USA. 86:1989;5054-5058.
11. Donnenberg M., Kaper J. Construction of an eae deletion mutant of enteropathogenic E. coli using a positive selection suicide vector. Infect. Immun. 59:1991;4310-4317.
12. Hohmann E.L., Oletta C.A., Miller S.I. Evaluation of a phoP/phoQ-deleted aroA-deleted live oral Salmonella typhi vaccine strain in human volunteers. Vaccine. 26:1995;14-19.
13. Sambrook J., Fritsch E.F., Maniatis T. Molecular cloning: a laboratory manual. 1989;Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
14. Green S.M., Malik T., Giles I.G., Drabble W.T. The purB gene of Escherichia coli K-12 is located in an operon. Microbiology. 142:(11):1996;3219-3230.
15. He B., Smith J.M., Zalkin H. Escherichia coli purB gene: cloning, nucleotide sequence and regulation by purR. J. Bacteriology. 174:1992;130-136.
16. Sanderson K.E., MacLachlan P.R., Hessel A. Electrotransformation in Salmonella. Methods in Molecular Biology. 47:1995;115-123.
17. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 227:1970;680-685.
18. Kleanthous H., Tibbets T.J., Bakios G., et al. In vivo selection of a highly adapted Helicobacter pylori isolate and the development of a H. pylori mouse model for studying vaccine efficacy and attenuating lesions. Gut. 37:1996;A94.
19. Levine M.M., Kaper J., Herrington D., et al. Safety, immunogenicity and efficacy of recombinant live oral cholera vaccine, CVD 103 and CVD103-HgR. Lancet. 2:(8609):1988;467-470.
20. Michetti P., Kreiss C., Kotloff K.L., Porta N., Blanco J.L., Bachmann D., Herranz M., Saldinger P.F., Crothesy-Theulaz I., Losonsky G., Nichols R., Simon J., Stolte M., Ackerman S., Monath T.P., Blum A.L. Oral immunization with urease and E. coli heat-labile enterotoxin is safe and immunogenic in H. pylori infected adults. Gastroenterology. 116:1999;804-812.
21. Ibrahim G.I., Fleet G.H., Lyons M.J., Walker R.J. Method for isolation of highly purified Salmonella flagellins. Journal of Clinical Microbiology. 22:1985;1040-1044.
22. Forrest B.D. Identification of an intestinal immune response using peripheral blood lymphocytes. Lancet. 1:1988;81-83.
23. Sack D. Personal communication, 1997.
24. Coynault C., Robbe-Saul V., Norel F. Virulence and vaccine potential of S. typhimurium mutants deficient in the expression of RpoS (sigma S) regulon. Molecular Microbiology. 22:1996;149-160.
25. Robbe-Saule V., Coynault C., Norel F. The live oral typhoid vaccine Ty21a is an rpoS mutant and is susceptible to various environmental stresses. Fems Microbiol. Lett. 126:1995;171-176.
26. Faulde M., Cremer J., Zoller L. Humoral immune response against Helicobacter pylori as determined by immunoblot. Electrophoresis. 14:1993;945-951.
27. Cuenca R., Blanchard T.G., Czinn S.J., Nedrud J.G., Monath T.P., Lee C.K., Redline R.W. Therapeutic immunization against Helicobacter mustelae in natural infected ferrets. Gastroenterology. 110:1996;2003-2006.
28. Dubois A., Lee C.K., Fiala N., Kleanthous H., Mehlman P.T., Monath T. Immunization against natural Helicobacter pylori infection in nonhuman primates. Infect. Immun. 66:1998;4340-4346.
29. Gentschev I., Glaser I., Goebel W., McKeever D.J., Musoke A., Heussler V.T. Delivery of the p67 Sporozoite antigen of Theileria parva by using recombinant Salmonella dublin: secretion of the product enhances antibody responses in cattle. Infect. Immun. 66:1998;2060-2064.
30. Hess J., Gentschev I., Miko D., Welzel M., Goebel W., Kaufman S.H. Superior efficacy of secreted over somatic antigen display in recombinant Salmonella vaccine induced protection against listeriosis. Proc. Natl. Acad. Sci. USA. 93:1996;1458-1463.
31. Hess J., Dietrich G., Gentchev I., Miko D., Goebel W., Kaufman S.H. Protection against murine listeriosis by an attenuated recombinant Salmonella typimurium vaccine strain that secretes the naturally somatic antigen superoxide dismutase. Infect. Immun. 65:1997;1286-1292.
32. VanCott J.L., Chatfield S.N., Roberts M., Hone D.M., Hohmann E.L., Pascual D.W., Yamamoto M., Kiyono H., McGhee J.R. Regulation of host immune responses by modification of Salmonella virulence genes. Nature Medicine. 11:1998;1247-1252.
33. Ogra P.L. Mucosal immune response to poliovirus vaccine in childhood. Rev. Infect. Dis. 6:(S2):1984;S361-S368.